News

TS DOST 2025: The Telangana State Council of Higher Education (TSCHE) has officially released the TS DOST 2025 phase 3 seat allotment list for undergraduate (UG) admissions.
VEGA-3 Phase 3 Study VEGA-3 is the second Phase 3 clinical trial evaluating the safety and efficacy of Phentolamine Ophthalmic Solution 0.75% in subjects with presbyopia.
Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.
Buoyed by data from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's drug from its Brainshuttle programme ...
The Green Party is concerned the Government’s decision to abandon an alliance on phasing out oil and gas production will undermine New Zealand’s global ...
Highly efficient three-phase to three-phase matrix converters using Gallium nitride (GaN) bidirectional switches with both high current and high breakdown voltage are demonstrated. The GaN switch with ...
A method of robust causal approximate nonminimum phase output tracking is considered. The problem of approximate tracking is solved for one class of nonlinear M ...
The phase 3 SUPERNOVA trial aimed to address the evidence gap from previous studies by evaluating sipavibart, an anti-spike monoclonal antibody, for the prevention of COVID-19 in a population with a ...
The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants ...
Mitapivat could be a new oral treatment for adults with NTD α-thalassaemia or NTD β-thalassaemia by increasing haemoglobin concentration and improving fatigue.
The IQ EV Charger 2 includes a Type-2 connector compatible with most electric vehicles in the region and can be configured for power levels up to 32 A per phase. It supports both single-phase and ...
Background: Gout is increasingly common disease in China. Dotinurad is a novel, selective urate reabsorption inhibitor, which reduces serum uric acid levels by selective inhibition of the urate ...